%PDF-1.4
%
35 0 obj
<>
endobj
70 0 obj
<>/Font<>>>/Fields[]>>
endobj
32 0 obj
<>
endobj
5 1 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2005-01-14T18:03:33Z
2024-03-28T01:39:32-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-28T01:39:32-07:00
application/pdf
Heather
2002-262.dec
uuid:b8f04caf-1dd1-11b2-0a00-5508276d7200
uuid:b8f04cb1-1dd1-11b2-0a00-b80000000000
endstream
endobj
21 0 obj
<>
endobj
22 0 obj
<>
endobj
36 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Rotate 0/Thumb 11 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Rotate 0/Thumb 13 0 R/Type/Page>>
endobj
79 0 obj
[83 0 R]
endobj
80 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.0318 Tw 9.7 0 0 10 54 324.1616 Tm
(in particular for evaluating acquired and congenital heart dis-)Tj
0.2319 Tw 0 -1.2 TD
(eases and thoracic vascular diseases. Besides morphologic)Tj
0.0005 Tw T*
(information on cardiac and thoracic great vessels, MRI exam-)Tj
0.1235 Tw T*
(inations can also evaluate ventricular function \(i.e., ejection)Tj
0.06841 Tw T*
[(fraction, stroke volumes, regur)17.7 (gitation fractions, cardiac out-)]TJ
0.2394 Tw T*
[(put\), tissue viability)64.8 (, and coronary artery morphology and)]TJ
0.00121 Tw T*
[(flow)64.8 (. Cardiac MRI does not require x-rays or injection of iod-)]TJ
0.0722 Tw T*
[(inated or radioactive contrast material. )17.7 (This represents a sig-)]TJ
0.06239 Tw T*
[(nificant safety advantage over other imaging modalities. )17.7 (The)]TJ
0.00819 Tw T*
(signal void from flowing blood on spin echo \(SE\) images and)Tj
-0.0126 Tw T*
(the high signal intensity from blood on GRE images eliminate)Tj
0.0083 Tw T*
(the requirement of contrast media injection for discrimination)Tj
0.1946 Tw T*
(of the blood pool from the cardiovascular solid structures.)Tj
0.02499 Tw T*
(Therefore, cardiac MRI can be totally noninvasive.)Tj
0.1011 Tw 1.2371 -1.18 Td
[(Spin echo imaging has been highly ef)17.7 (fective for imaging)]TJ
-0.0031 Tw -1.2371 -1.18 Td
(intracardiac masses)Tj
0 Tc 0 Tw 6.3 0 0 6.5 129.636 147.8617 Tm
(2)Tj
-0.00011 Tc -0.00301 Tw 9.7 0 0 10 132.7885 144.5616 Tm
[(. )17.7 (The most frequent intracardiac mass is a)]TJ
0.0186 Tw -8.1225 -1.18 Td
(thrombus, which is usually located in the left heart chambers.)Tj
0.0092 Tc 0.36571 Tw 0 -1.18 TD
[(MRI can dif)17.7 (ferentiate between tumor and nontumorous)]TJ
-0.00011 Tc 0.2379 Tw T*
(thrombus, a major advantage over echocardiography)Tj
0 Tc 0 Tw 6.3 0 0 6.5 269.6844 112.4616 Tm
(3)Tj
0.2379 Tw 9.7 0 0 10 272.8369 109.1617 Tm
(, and)Tj
-0.00011 Tc 0.2845 Tw -22.5605 -1.18 Td
[(this was clearly demonstrated in our patient. )17.7 (T)35 (umors are)]TJ
0.1841 Tw T*
[(hyperintense on SE )17.7 (T2 weighted images. Further)39.7 (, on GRE)]TJ
0.0125 Tc 0.3624 Tw T*
(images, a clot has lower signal intensity compared to)Tj
-0.00011 Tc -0.0117 Tw 27.2165 25.04 Td
(myocardium, where the tumor has intermediate signal intensi-)Tj
0.0065 Tc 0.36839 Tw T*
[(ty)64.8 (. If gadolinium \(superparamagnetic contrast media\) is)]TJ
-0.00011 Tc 0.07001 Tw T*
[(administered, tumor enhances, but thrombus does not. )17.8 (These)]TJ
-0.0282 Tw T*
[(signal characteristics are useful for dif)17.7 (ferentiating between the)]TJ
0.1366 Tw T*
(tumor and a clot. MRI also helps to define the age of clot,)Tj
0.1841 Tw T*
(which is very important to determine the most appropriate)Tj
0.2301 Tw T*
[(treatment. On SE images, fresh clot shows high intensity)64.8 (,)]TJ
0.02499 Tw T*
[(whereas an old clot has low signal intensity)64.8 (.)]TJ
0.18221 Tw 1.2371 -1.2 Td
(Clinicians should be aware of the usefulness and major)Tj
0.1107 Tw -1.2371 -1.2 Td
[(advantages of cardiac MRI for the dif)17.7 (ferentiation of cardiac)]TJ
0.02499 Tw 0 -1.2 TD
(masses, especially when echocardiography is inconclusive.)Tj
/T1_1 1 Tf
0 Tw 0 -2.4 TD
(REFERENCES)Tj
/T1_0 1 Tf
0.02499 Tw 8 0 0 8 325 171.7617 Tm
[(1.)-875.1 (W)39.8 (ilson )17.7 (W)110.9 (A, Gharavi )54.8 (AE, Koike )17.7 (T)74 (, et al. International consensus)]TJ
1.675 -1.225 Td
(statement on preliminary classification criteria for definite)Tj
0 -1.225 TD
(antiphospholipid syndrome: report of an international workshop.)Tj
T*
[(Arthritis Rheum 1999;42:1309-1)36.8 (1.)]TJ
-1.675 -1.225 Td
[(2.)-875.1 (Hof)17.7 (fmann U, Globitis S, Frank H. Cardiac and paracardiac masses:)]TJ
1.675 -1.225 Td
(current opinion on diagnostic evaluation by magnetic resonance)Tj
T*
(imaging. Eur Heart J 1998;19:553-63.)Tj
-1.675 -1.225 Td
[(3.)-875.1 (Seelos K, Caputo GR, Carol CL, et al. Cine gradient refocused)]TJ
1.675 -1.225 Td
[(\(GRE\) echo imaging of intravascular masses: dif)17.7 (ferentiation)]TJ
T*
[(between tumor and nontumorous thrombus. J Comput )54.8 (Assist)]TJ
0 Tc T*
[(T)70 (omogr 1992;16:169-75.)]TJ
ET
Q
Q
q
47 721 518 -389 re
W* n
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
q
360.9568 0 0 345.5969 124 376.4831 cm
/Im0 Do
Q
Q
Q
Q
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_2 1 Tf
-0.00011 Tc 0.0285 Tw 7.76 0 0 8 127 363.5293 Tm
[(Figur)36.8 (e 2.)]TJ
/T1_0 1 Tf
3.9914 0 Td
(ECG gated spin echo MRI in coronal \(A\), sagittal \(B\), and axial \(C\)\
planes and axial cross-sectional fast)Tj
0.0052 Tw -3.9914 -1.25 Td
(GRE bright blood cardiac MRI \(D\) reveal thrombus formations \(arrows\)\
in superior vena cava and left atrium \(RA:)Tj
0.02499 Tw 0 -1.25 TD
[(right atrium, R)79.7 (V)73.9 (: right ventricle, LA: left atrium, L)91.7 (V)73.9 (: left ventricle, )54.8 (A: aorta, SVC: superior vena cava\).)]TJ
ET
0 0 0 1 K
54 54 m
558 54 l
S
BT
/T1_2 1 Tf
8 0 0 8 54.5 35.9844 Tm
[(Erkan, et al: Car)36.8 (diac MRI in )17.7 (APS)]TJ
0 Tc 0 Tw 60.9375 -0.0313 Td
(2659)Tj
ET
0 0 0 0 k
/GS0 gs
101.07 59.75 407.5 -10.83 re
f*
0.5 w
101.07 59.75 407.5 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_3 8 Tf
120.092 51 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2002. All rights reserved.)Tj
ET
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_3 8 Tf
120.092 51 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2002. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_4 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
13 0 obj
<>stream
8;Z\7$^N"\#in2)L\l<j9mCArr>
lir(Y=E(d2^hATYZ%O:M4R0HI0p(ITm2*Q0hsr:J>`Zn/Y)Xmi#F>e%*F:IV>Rgmj
?VoTA^EUI9K)+X"R>5^H^dn]"3+0B!96POlG@s>c0ILJ.O:h1#nUP1Ar#P6CEXA_:
?ab]NRj%ag[?hOo+L3"%`E"Es$DoEoMfC,)SeCBFfkn#VK4b^R$9EnOYi=HtBn4rohJ,frW
kEV$J2=>/uN*98/<'rg9%bpBSk&l6eq-L'SH4e\1;hZPg"29
jQ'H#?F%n8EaSLf9U"(i*W.hd91D511nI/VBa03uj(KI.fQe#jhrrRCLN@Te\P7h/
A^gh1ZWAO;.UIQpl9U><)2VZhEO](ZiTP.A?$qYg=OS3YHg4=!V/:d_M`fUj/H!b`C0[&W:Y2])T``;JCXIJW"e6#8Ok-^j\gMuoI[_lIFnLj>h
QCb\U6[`%rdo_Nknp*5'?7U:ha#5l[l0a#-iRd`dS"&W"h"@C1<@_Y\ARd?]\etF
:uk/neX<7X
endstream
endobj
19 0 obj
[/Indexed/DeviceRGB 255 18 0 R]
endobj
18 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
4 0 obj
<>stream
Adobe d C
hx /
s !1AQa"q2B#R3b$r%C4Scs5D'6Tdt&
EFVU(eufv7GWgw8HXhx)9IYiy*:JZjz ? w_|V=Oj/ 9lykGrɚΗ>{{2-+{w~+[.xdO?ϋi#ԭ0v(
72Ka緰I5{cpfg4bE?4?:J',Tpv$ueWZ
6t{r@kI$h<v[X= ?+ =-5{,6<ikȒZS}!, , >gA;LLj4ڃJsZgU
ֹEE *CCSÿJaw_Zߣٱx%hV_ί8y쵏24N\[+`mJx%,S˗
>FXy1z$0u0HSޕr@lb,W74p1s$&a.yHLbQ{V Thݻ{/W筄'ԍ%AVP*?fh
G:$&I}|ON?j։Ug;$>RKQ65R ѕ5@ huj-ecaN<-m t_e֮|`6"7#њk1ɟwGCеM
]V[YI]BƁ_JXji9 ˕8-Q{I47@ 4ѩIh? KSZ( -h%cnZvcȕoΡ{
hm[b@ڗka,7c[Bןzv4 }sIOBV|54>_V
Ŕxl_! ќS&KQ